Retrieve available abstracts of 17 articles: HTML format
Single Articles
May 2025
ABUKMAIL E, Pradeep NK, Ahmed S, Albarqouni L, et al Moderate- to Long-Term Effect of Dietary Interventions for Depression and Anxiety
: A Systematic Review and Meta-analysis.
Ann Intern Med. 2025 May 20. doi: 10.7326/ANNALS-24-03016. PubMedAbstract available
Summary for Patients: Moderate- to Long-Term Effect of Dietary Interventions for
Depression and Anxiety.
Ann Intern Med. 2025 May 20. doi: 10.7326/ANNALS-24-03016. PubMed
Annals Video Summary - Moderate- to Long-Term Effect of Dietary Interventions for
Depression and Anxiety: A Systematic Review and Meta-analysis.
Ann Intern Med. 2025 May 20:e2501280VS. doi: 10.7326/ANNALS-25-01280. PubMed
February 2025
TANG H, Lu Y, Donahoo WT, Westen SC, et al Glucagon-Like Peptide-1 Receptor Agonists and Risk for Depression in Older Adults
With Type 2 Diabetes : A Target Trial Emulation Study.
Ann Intern Med. 2025 Feb 25. doi: 10.7326/ANNALS-24-01347. PubMedAbstract available
LEUNG LB In nonseasonal depressive disorders, bright light therapy improves response and
remission rates.
Ann Intern Med. 2025;178:JC21. PubMedAbstract available
August 2024
WEI YJ, Winterstein AG, Schmidt S, Fillingim RB, et al Clinical and Adverse Outcomes Associated With Concomitant Use of
CYP2D6-Metabolized Opioids With Antidepressants in Older Nursing Home Residents :
A Target Trial Emulation Study.
Ann Intern Med. 2024;177:1058-1068. PubMedAbstract available
DOBRESCU AI, Persad E, Klerings I, Gartlehner G, et al Update Alert 2: Nonpharmacologic and Pharmacologic Treatments of Adult Patients
With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis for
a Clinical Guideline by the American College of Physicians.
Ann Intern Med. 2024;177:e2400428. PubMed
QASEEM A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte JE, et al Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of
Major Depressive Disorder: A Living Clinical Guideline From the American College
of Physicians (Version 1, Update Alert 2).
Ann Intern Med. 2024;177:e2400593. PubMed
April 2024
QASEEM A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte JE, et al Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of
Major Depressive Disorder: A Living Clinical Guideline From the American College
of Physicians (Version 1, Update Alert).
Ann Intern Med. 2024;177:eL230440. PubMed
DOBRESCU AI, Persad E, Klerings I, Gartlehner G, et al Update Alert: Nonpharmacologic and Pharmacologic Treatments of Adult Patients
With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for
a Clinical Guideline by the American College of Physicians.
Ann Intern Med. 2024;177:eL230441. PubMed
QASEEM A, Andrews RA, Campos K, Goldzweig CL, et al Quality Indicators for Major Depressive Disorder in Adults: A Review of
Performance Measures by the American College of Physicians.
Ann Intern Med. 2024;177:507-513. PubMedAbstract available
January 2024
ISHIGUCHI H, Lip GYH In symptomatic AF, catheter ablation vs. medical therapy reduced depression and
anxiety symptoms at 12 mo.
Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0105. PubMedAbstract available
September 2023
HOLSINGER T, Riordan P In treatment-resistant major depression, ketamine was noninferior to ECT for
treatment response.
Ann Intern Med. 2023 Sep 5. doi: 10.7326/J23-0068. PubMedAbstract available
February 2023
QASEEM A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte J, et al Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of
Major Depressive Disorder: A Living Clinical Guideline From the American College
of Physicians.
Ann Intern Med. 2023;176:239-252. PubMedAbstract available
GARTLEHNER G, Dobrescu A, Chapman A, Toromanova A, et al Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major
Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical
Guideline by the American College of Physicians.
Ann Intern Med. 2023;176:196-211. PubMedAbstract available
AFFENGRUBER L, Wagner G, Dobrescu A, Toromanova A, et al Values and Preferences of Patients With Depressive Disorders Regarding
Pharmacologic and Nonpharmacologic Treatments : A Rapid Review.
Ann Intern Med. 2023;176:217-223. PubMedAbstract available
DOBRESCU A, Chapman A, Affengruber L, Persad E, et al Cost-Effectiveness of First- and Second-Step Treatment Strategies for Major
Depressive Disorder : A Rapid Review.
Ann Intern Med. 2023;176:212-216. PubMedAbstract available